The Linked Clinical Trials initiative (LCT) for Parkinson's disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Linked Clinical Trials initiative (LCT) for Parkinson's disease
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-30
DOI
10.1111/ejn.14175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
- (2018) Seung Pil Yun et al. NATURE MEDICINE
- Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease
- (2018) Dilan Athauda et al. NEUROPHARMACOLOGY
- What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis
- (2018) Dilan Athauda et al. Journal of Parkinsons Disease
- Post hoc analysis of the Exenatide-PD trial - factors that predict response
- (2018) Dilan Athauda et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Precision medicine for disease modification in Parkinson disease
- (2017) Alberto J. Espay et al. Nature Reviews Neurology
- c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential
- (2017) Saurav Brahmachari et al. Journal of Parkinsons Disease
- Challenges of Improving Patient-Centred Care in Parkinson’s Disease
- (2017) Soania Mathur et al. Journal of Parkinsons Disease
- Is Exenatide a Treatment for Parkinson’s Disease?
- (2017) Dilan Athauda et al. Journal of Parkinsons Disease
- Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress
- (2017) Camille B. Carroll et al. Journal of Parkinsons Disease
- Insulin resistance and Parkinson’s disease: A new target for disease modification?
- (2016) D. Athauda et al. PROGRESS IN NEUROBIOLOGY
- Nilotinib – Differentiating the Hope from the Hype
- (2016) Richard K. Wyse et al. Journal of Parkinsons Disease
- Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease
- (2015) Karl Kieburtz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Rising to the Challenges of Clinical Trial Improvement in Parkinson’s Disease
- (2015) Soania Mathur et al. Journal of Parkinsons Disease
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease
- (2008) CLINICAL NEUROPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started